|
Fluvoxamine Maleate
1-Pentanone, 5-methoxy-1-[4-(trifluoromethyl)phenyl]-, O-(2-aminoethyl)oxime, (E)-, (Z)-2-butenedioate (1:1). 5-Methoxy-4¢-(trifluoromethyl)valerophenone (E)-O-(2-aminoethyl)oxime, maleate (1:1) » Fluvoxamine Maleate contains not less than 98.0 percent and not more than 102.0 percent of C15H21F3N2O2·C4H4O4, calculated on the dried basis.
Packaging and storage
Preserve in well-closed, light-resistant containers. Store at controlled room temperature.
Identification
B:
The retention time of the major peak in the chromatogram of the Assay preparation corresponds to that in the chromatogram of the Standard preparation, as obtained in the Assay.
Loss on drying
Residue on ignition
Heavy metals, Method II
Related compounds
Buffer solution, Mobile phase, Resolution solution, and Chromatographic system
Proceed as directed in the Assay.
Identification solution
Dissolve a quantity of maleic acid in Mobile phase, and dilute quantitatively, and stepwise if necessary, with Mobile phase to obtain a solution having a known concentration of about 0.35 mg per mL.
Standard solution
Use the Standard preparation, prepared as directed in the Assay.
Test solution
Use the Assay stock preparation, prepared as directed in the Assay.
Procedure
Separately inject equal volumes (about 20 µL) of the Standard solution, the Test solution, and the Identification solution into the chromatograph, record the chromatograms, and measure the responses for the major peaks. Calculate the percentage of impurities in the portion of Fluvoxamine Maleate taken by the formula:
5000(C/W)F(ri / rS)
in which C is the concentration, in mg per mL, of USP Fluvoxamine Maleate RS in the Standard solution; W is the weight, in mg, of Fluvoxamine Maleate used to prepare the Test solution; F is the response factor of each impurity as given in Table 1; ri is the individual peak area of each impurity in the Test solution; and rS is the peak area of fluvoxamine maleate in the Standard solution. The limits of impurities are specified in Table 1. [noteDisregard any peak due to maleic acid or the reagent blank.]
Table 1
Assay
Buffer solution
Dissolve about 5 g of 1-pentanesulfonic acid sodium salt and 0.7 g of monobasic potassium phosphate in 620 mL of water. Adjust with phosphoric acid to a pH of 3.00 ± 0.05.
Mobile phase
Prepare a filtered and degassed mixture of Buffer solution and acetonitrile (62:38). Make adjustments if necessary (see System Suitability under Chromatography
Resolution solution
Transfer about 6 mg of Fluvoxamine Maleate to a 50-mL volumetric flask. Heat the sample at 120
Standard preparation
Dissolve an accurately weighed quantity of USP Fluvoxamine Maleate RS in Mobile phase, and dilute quantitatively, and stepwise if necessary, with Mobile phase to obtain a solution having a known concentration of about 0.05 mg per mL.
Assay stock preparation
Transfer an accurately weighed quantity of about 50 mg of Fluvoxamine Maleate to a 50-mL volumetric flask, dissolve in and dilute with Mobile phase to volume, and mix.
Assay preparation
Transfer 5.0 mL of the Assay stock preparation to a 100-mL volumetric flask. Dilute with Mobile phase to volume, and mix.
Chromatographic system (see Chromatography
Procedure
Separately inject equal volumes (about 20 µL) of the Standard preparation and the Assay preparation into the chromatograph, record the chromatograms, and measure the responses for the fluvoxamine maleate peaks. Calculate the quantity, in mg, of C15H21F3N2O2·C4H4O4 in the portion of Fluvoxamine Maleate taken by the formula:
1000C(rU / rS)
in which C is the concentration, in mg per mL, of USP Fluvoxamine Maleate RS in the Standard preparation; and rU and rS are the peak areas obtained from the Assay preparation and the Standard preparation, respectively.
Auxiliary Information
Please check for your question in the FAQs before contacting USP.
Chromatographic Column
USP32NF27 Page 2441
Pharmacopeial Forum: Volume No. 32(5) Page 1449
Chromatographic columns text is not derived from, and not part of, USP 32 or NF 27.
|